Errata


In (1), the author names were listed incorrectly. The correct author list is given below.

Takuma Teratani, Haruhiko Yoshida, Shuichiro Shiina, Shuntaro Obi, Shinpei Sato, Yukihiro Koike, Keisuke Hamamura, Masatoshi Akamatsu, Tomonori Fujishima, Yasuo Imai, Takao Kawabe, Yasushi Shiratori and Masao Omata.

In (2), an incorrect version of Table 2 was published and the key to Figure 1 was omitted. Correct versions appear below.

Table 2.   Biochemical, serological and virological response and outcome
VariableBefore treatment*After treatment*
  • *

    Peak levels. ALT, alanine aminotransferase; INR, international normalized ratio; HBsAg, hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBeAg, hepatitis e antigen; HBeAb, hepatitis e antibody; HBV, hepatitis B virus.

ALT (U/l) (mean±SD)3738±1659<40
INR (mean±SD)4.5±6.4<1.0
Factor 5 (%) (mean±SD)35.0±7Not done
Bilirubin (mg/dl) (mean±SD)18.0±6.81.0
HBsAg positivity (n (%))15 (100)0 (0)
HBsAb positivity (n (%))0 (0)9 (81.81)
HBeAg positivity (n (%))11 (84.61)0 (0)
HBeAb positivity (n (%))2 (15.38)9 (81.81)
HBV DNA (copies/ml) (mean±SD)13.4 × 106±11.0 × 106<200
Outcome (n (%))
 Alive 14 (93.33)
 Transplant 2 (13.33)
 Died 1 (6.66)
Figure 1.

 Biochemical, serological and virological response following lamivudine treatment in one of the patients.

Ancillary